Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Nasal decongestants

1

XVI.bl Imaging: An area or areas of avid tracer uptake in the lung/chest on 18F-PET scan

1
Last update : 09/11/2016
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Oil-/lipid-based formulations (parenteral)
3
Paraffin-Vaseline-Oil-Lipids (Mineral or other) p.o./inhaled/aspirated
5

Publications

Exogenous lipoid pneumonia induced by nasal decongestant.
The clinical respiratory journal 2018 Feb;12;524-531 2018 Feb

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies